NanoCas, a smaller version of CRISPR tested with a single AAV, delivers on-target results

Mammoth Biosciences researchers have developed NanoCas, an ultracompact CRISPR nuclease, demonstrating its ability to perform ...
Indiatimes

. "During this experiment for about a month at a village in Sudan, only 20 to 30 people got infected by vector-borne diseases. Prior to the experiment, 100 people had been ...

"During this experiment for about a month at a village in Sudan, only 20 to 30 people got infected by vector-borne diseases. Prior to the experiment, 100 people had been affected", Kumar added. This ...
Asian News International

Researchers experiment with gene therapy vector injections to cure renal disease

New York [USA], Jan 1 (ANI): Mastering the targeted delivery of therapeutic genes to the desired location within the body is the first necessary step towards implementing gene therapy to treat renal ...